Cardiac ArrestACR90NCT05523999
Recognition of a Cardiac Arrest Within the EMS
An observational study of Cardiac Arrest, run by Hôpital NOVO at 1 site in France.
Trial summary
This study aims to evaluate the average time taken by the Medical Regulation Assistants (MRA) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cardiac Arrest
- What is being tested?
- Time elapsed between the taking in charge of the call and the recognition of a cardiac arrest by the MRA
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 3 Jun 2024to Apr 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Medical regulation assistant taking a call from a witness of a cardiac arrest between 01/01/2024 and 30t/04/2024
Who may be able to join
- Any call resulting in the detection of a cardiac arrest during ARM regulation: calls to 15 and calls transmitted by 18
Who cannot join
- Traumatic context
- Call involving cardiac arrest already identified as such by the caller or 18
- Call with criteria of proven death
- The caller does not speak French, the linguistic elements noted are not usable.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
EMS department - Hospital René Dubos - Pontoise
Pontoise, 95300
Dr Ariane Zoya-Gillet, +33 1 30 75 40 15, ariane-zoya.gillet@ght-novo.fr]
Julie Narcisse, +33 1 30 75 40 15, narcisseju@gmail.com
About this study
Official title: Evaluation of the Optimal Time of Recognition of a Cardiac Arrest Within the EMS 95
This study aims to evaluate the average time taken by the Medical Regulation Assistants (MRA) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.
Its main objective is to evaluate the delay, in seconds, between the call being picked up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95
Read the detailed description
In France, the incidence of cardiac arrest in adults is approximately 40,000 per year. It is a major cause of mortality with an average survival rate of 8%, as well as morbidity, particularly neurological morbidity for surviving patients. The majority of cardiac arrests occur at In France, the incidence of cardiac arrest in adults is approximately 40,000 per year. It is a major cause of mortality with an average survival rate of 8%, as well as morbidity, particularly neurological morbidity for surviving patients. The majority of cardiac arrests occur at home, in the presence of a witness.
In the event of a cardiac arrest, every minute counts. Studies have shown that the time between the patient's collapse and the start of ECM (External Cardiac Massage) is directly correlated to the survival rate after a cardiac arrest.
According to other studies, a maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest would be the most optimal for the patient, but is it reached at the EMS 95? This study aims at evaluating the average time taken by the Assistants of Medical Regulation (ARM) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.
Its main objective is to evaluate the delay, in seconds, between the call pick-up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95. This evaluation will be made in particular by determining the elements of language highlighting the cardiac arrest, those which lengthen the time of detection of the arrest and the delay of starting a procedure by the ARM. The study will be conducted within the EMS and will include a review of the current state of knowledge and experience of the MRAs. This study will be carried out within the EMS 95.
- Conditions
- Cardiac Arrest
- Being tested
- Time elapsed between the taking in charge of the call and the recognition of a cardiac arrest by the MRA
- Keywords
- cardiorespiratory arrest (CRA), Medical Regulation Assistant (MRA), EMS, External Cardiac Massage, External Automated Defibrillator, 90 seconds
- Medical subject headings
- Heart Arrest
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Time elapsed between the taking in charge of the call and the recognition of a cardiac arrest by the MRAOther
Prospective study within the EMS 95, to evaluate if the maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest is reached.
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation, of the time elapsed (seconds) between the taking in charge of the call and the recognition of a cardiac arrest by the medical regulation assistant (ARM) of the EMS 95.
Measure of the time in seconds between picking up the phone and the recognition of the cardiac arrest by the medical regulation assistant
Measured: At the end of the study, an average of 5 month
Secondary outcomes (4)
Identify language that highlights cardiac arrest
Collection of the initial reason for appeal and everything said by the witness that may point to cardiac arrest
Measured: At the end of the study, an average of 5 month
Identify language that increases the time to detect cardiac arrest
Collection of everything said by the witness increasing the detection of the cardiac arrest
Measured: At the end of the study, an average of 5 month
Evaluation of the time required for the MRA to initiate a procedure (AED search: External Automated Defibrillator or initiation of external cardiac massage assistance)
Collection of time (seconds) between :
- the MRA taking the call and requesting an AED search
- the MRA taking the call and the start of external cardiac massage
Measured: At the end of the study, an average of 5 month
Identification of factors that may influence the time to recognition of cardiac arrest (MRA experience, tone of the call)
Collection of call tone (witness anxiety level) and MRA experience in years
Measured: At the end of the study, an average of 5 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Sep 2022
- Study start3 Jun 2024
- Primary completionApr 2025 (estimated)
- Study completionApr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiac ArrestStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hôpital NOVO
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Dr Ariane Zoya-Gillet, Principal investigator, Hôpital NOVO
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05523999
- Sponsor's protocol ID
- CHRD2321
- Acronym
- ACR90
- Status last verified
- Dec 2024
- First submitted
- 29 Aug 2022
- Last updated
- 31 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Optimal Time of Recognition of a Cardiac Arrest Within the EMS 95
- ClinicalTrials.gov ID
- NCT05523999
- Acronym / sponsor ID
- ACR90 / CHRD2321
- Conditions
- Cardiac Arrest
- Keywords
- cardiorespiratory arrest (CRA), Medical Regulation Assistant (MRA), EMS, External Cardiac Massage, External Automated Defibrillator, 90 seconds
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Hôpital NOVOUniversity, hospital or other
- Study start
- 3 Jun 2024 (actual)
- Primary completion
- Apr 2025 (estimated)
- Study completion
- Apr 2025 (estimated)
- First posted
- 1 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the average time taken by the Medical Regulation Assistants (MRA) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.
Its main objective is to evaluate the delay, in seconds, between the call being picked up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95
Detailed description
In France, the incidence of cardiac arrest in adults is approximately 40,000 per year. It is a major cause of mortality with an average survival rate of 8%, as well as morbidity, particularly neurological morbidity for surviving patients. The majority of cardiac arrests occur at In France, the incidence of cardiac arrest in adults is approximately 40,000 per year. It is a major cause of mortality with an average survival rate of 8%, as well as morbidity, particularly neurological morbidity for surviving patients. The majority of cardiac arrests occur at home, in the presence of a witness.
In the event of a cardiac arrest, every minute counts. Studies have shown that the time between the patient's collapse and the start of ECM (External Cardiac Massage) is directly correlated to the survival rate after a cardiac arrest.
According to other studies, a maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest would be the most optimal for the patient, but is it reached at the EMS 95? This study aims at evaluating the average time taken by the Assistants of Medical Regulation (ARM) to detect a cardiac arrest during the call to the EMS as well as the factors influencing this delay.
Its main objective is to evaluate the delay, in seconds, between the call pick-up and the recognition of a cardiac arrest by the medical regulation assistant at the EMS 95. This evaluation will be made in particular by determining the elements of language highlighting the cardiac arrest, those which lengthen the time of detection of the arrest and the delay of starting a procedure by the ARM. The study will be conducted within the EMS and will include a review of the current state of knowledge and experience of the MRAs. This study will be carried out within the EMS 95.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Medical regulation assistant taking a call from a witness of a cardiac arrest between 01/01/2024 and 30t/04/2024
Key inclusion criteria (1 listed)
- Any call resulting in the detection of a cardiac arrest during ARM regulation: calls to 15 and calls transmitted by 18
Key exclusion criteria (4 listed)
- Traumatic context
- Call involving cardiac arrest already identified as such by the caller or 18
- Call with criteria of proven death
- The caller does not speak French, the linguistic elements noted are not usable.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Time elapsed between the taking in charge of the call and the recognition of a cardiac arrest by the MRAProspective study within the EMS 95, to evaluate if the maximum delay of 90 seconds between the call to the EMS and the recognition of the cardiac arrest is reached. | Other | – |
Primary outcome
Evaluation, of the time elapsed (seconds) between the taking in charge of the call and the recognition of a cardiac arrest by the medical regulation assistant (ARM) of the EMS 95.
Time frame: At the end of the study, an average of 5 month
Measure of the time in seconds between picking up the phone and the recognition of the cardiac arrest by the medical regulation assistant
4 secondary outcomes
Identify language that highlights cardiac arrest
Time frame: At the end of the study, an average of 5 month
Identify language that increases the time to detect cardiac arrest
Time frame: At the end of the study, an average of 5 month
Evaluation of the time required for the MRA to initiate a procedure (AED search: External Automated Defibrillator or initiation of external cardiac massage assistance)
Time frame: At the end of the study, an average of 5 month
Identification of factors that may influence the time to recognition of cardiac arrest (MRA experience, tone of the call)
Time frame: At the end of the study, an average of 5 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Dec 2024.
- Individual participant dataSharing planned: No
Related trials for Cardiac Arrest
RecruitingObservational study
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
Cardiomyopathies, Cardiac Arrest
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruitingObservational study
CAROTID DOPPLER AND CEREBRAL OXIMERY IN POST CARDIAC ARREST ICU PATIENTS
Cardiac Arrest (CA), Carotid Doppler
Active, not recruitingPhase 3
The Danish Out-of-Hospital Cardiac Arrest Study
Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome
RecruitingObservational study
Evaluation of Acid-base Disorders and Ventilation Settings in Cardiogenic Shock and Post-cardiac Arrest Patients: Comparison With VentilO Algorithm
Cardiac Arrest (CA), Cardiogenic Shock
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dr Ariane Zoya-Gillet principal investigator
Hôpital NOVO
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiac Arrest, run by Hôpital NOVO at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 31 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Maryline Delattre (+33 1 30 75 41 31, maryline.delattre@ght-novo.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation, of the time elapsed (seconds) between the taking in charge of the call and the recognition of a cardiac arrest by the medical regulation assistant (ARM) of the EMS 95. (time frame: At the end of the study, an average of 5 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2024.